as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹3,348.4
Change
-3.4 (-0.1%)
Open
₹3,333.0
Prev. Close
₹3,351.8
Day High
₹3,377.0
Day Low
₹3,328.0
Volume Analysis
Traded
146,070
Delivered
133,349
Delivery %
91.29%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Strengths, Weaknesses, Opportunities & Threats
Strengths (0)
No signal for this stock
Weaknesses (1)
- •Low operating margin (4.8%)
Opportunities (0)
No signal for this stock
Threats (0)
No signal for this stock
Rule-based signals from the fundamentals below — not investment advice.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹3,423.26 | ₹3,400.13 | ₹3,374.26 | ₹3,351.13 | ₹3,325.26 | ₹3,302.13 | ₹3,276.26 |
| Fibonacci | ₹3,400.13 | ₹3,381.41 | ₹3,369.85 | ₹3,351.13 | ₹3,332.41 | ₹3,320.85 | ₹3,302.13 |
| Camarilla | ₹3,361.88 | ₹3,357.38 | ₹3,352.89 | ₹3,351.13 | ₹3,343.91 | ₹3,339.42 | ₹3,334.93 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-26.3%
1 Week
-3.61%
1 Month
-5.63%
3 Months
-17.76%
6 Months
-23.6%
1 Year
-26.54%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Stock Vitals
Computed from the latest available annual financials.
Graham Number
₹163.32
Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.
DuPont ROE Breakdown
16.59%
Net margin 7.57% × asset turnover 0.8x × equity multiplier 2.74x
Company Overview
Sector
Chemicals
Market Cap
₹15,266 Cr
P/E (TTM)
310.0
ROE
15.8%
Book Value
₹84.5
Face Value
₹10.0
Source: Screener.in (Consolidated figures) — data as of 16 Nov 2026. Not investment advice.
TopFund Analysis
Bayer Cropscience Ltd lands in the middle of the pack on TopFund's composite fundamentals check within the Chemicals sector, at 51/100. The strongest factor is Financial Strength (98/100), while Momentum (9/100) is the weakest area to weigh before deciding. Notably: Low operating margin (4.8%).
TopFund Score — Fundamentals Quality
51/100 — AverageData confidence: 76/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Financial Strength
Valuation
Cash Flow
Corporate Governance
Momentum
Institutional Ownership
Business Quality
Risk & Volatility
Liquidity
From Screener.in
- −Stock is trading at 40.3 times its book value
- −Company might be capitalizing the interest cost
- −Earnings include an other income of Rs.83.7 Cr.
Not investment advice — an automated read of public fundamentals data, for research context only.
Corporate Actions
As per Regulation 47 of SEBI LODR Regulations 2015, please find attached herewith the newspaper advertisement for the unaudited financial results for the quarter and …
Submission of newspaper notice for attention of shareholders with respect to intimation of Record Date for Interim Dividend for FY 2026-27
Bayer CropScience reported Q2/H1 FY27 results and declared ₹90 interim dividend per share on November 3, 2026.
Dr. Thomas Hoffmann resigns Nov 30, 2026; Ms. Christiane Temminghoff appointed from Dec 1; Rajaram Boppana resigns Dec 31.
Dr. Thomas Hoffmann resigns Nov 30, 2026; Christiane Temminghoff appointed Dec 1; Rajaram Boppana resigns Dec 31.
Source: BSE regulatory filings, via Screener.in.
Quarterly Results
Last several quarters
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Sales + | 223 | 242 |
| Expenses + | 194 | 225 |
| Operating Profit | 29 | 18 |
| OPM % | 13.0% | 7.0% |
| Other Income + | 7 | 18 |
| Interest | 2 | 3 |
| Depreciation | 6 | 6 |
| Profit before tax | 27 | 27 |
| Tax % | 71.0% | 36.0% |
| Net Profit + | 8 | 17 |
| EPS in Rs | 2 | 4 |
| Raw PDF | — | — |
| YoY Sales growth | — | 9 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Profit & Loss (Yearly)
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Sales + | 667 | 727 |
| Expenses + | 610 | 692 |
| Operating Profit | 57 | 35 |
| OPM % | 9.0% | 4.8% |
| Other Income + | 50 | 84 |
| Interest | 8 | 9 |
| Depreciation | 23 | 23 |
| Profit before tax | 77 | 87 |
| Tax % | 50.0% | 36.0% |
| Net Profit + | 38 | 55 |
| EPS in Rs | 10 | 14 |
| Dividend Payout % | 23.0% | 17.0% |
| Sales growth | — | 9 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Balance Sheet
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Reserves | 250 | 294 |
| Borrowings + | 120 | 112 |
| Other Liabilities + | 436 | 468 |
| Total Liabilities | 846 | 914 |
| Fixed Assets + | 161 | 153 |
| CWIP | 8 | 4 |
| Investments | 4 | 4 |
| Other Assets + | 674 | 754 |
| Total Assets | 846 | 914 |
| Equity Capital | 40 | 40 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Cash Flow
| Dec 2005 | Dec 2006 | |
|---|---|---|
| Cash from Operating Activity + | -12 | 38 |
| Cash from Investing Activity + | -34 | -16 |
| Cash from Financing Activity + | 25 | -26 |
| Net Cash Flow | -21 | -4 |
| Free Cash Flow | -56 | 21 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 43 | 208 |
Source: Screener.in — figures in ₹ Crores unless marked %.
Shareholding Pattern
Quarter-by-quarter — Promoters, FII, DII & public holding trend
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Public | 12.33% | 12.15% | 12.47% | 13.18% | 13.45% | 13.53% | 13.55% | 13.56% | 13.27% | 12.79% | 12.96% | 13.09% |
| Promoters | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% | 71.44% |
| FII | 3.53% | 3.62% | 3.63% | 3.3% | 3.42% | 3.49% | 3.64% | 3.8% | 3.84% | 3.89% | 3.97% | 3.95% |
| DII | 12.7% | 12.8% | 12.47% | 12.08% | 11.69% | 11.56% | 11.38% | 11.22% | 11.47% | 11.89% | 11.64% | 11.52% |
Source: Screener.in — quarterly shareholding disclosures.
Peers Comparison
Chemicals — ranked by market cap
| Company | Market Cap (Cr) | P/E | P/B | ROE |
|---|---|---|---|---|
| Bayer Cropscience Ltd (this stock) | 15,266 | 310.0 | 40.2 | 15.8% |
| Tata Chemicals Ltd | 15,436 | — | 0.7 | 1.27% |
| Anupam Rasayan India Ltd | 14,991 | 83.1 | 2.97 | 5.55% |
| Chambal Fertilizers Ltd | 14,886 | 7.79 | 1.31 | 20.0% |
| Atul Ltd | 14,753 | 19.1 | 2.24 | 11.5% |
| Paradeep Phosphates Ltd | 14,582 | 16.8 | 2.03 | 16.2% |
| Fine Organic Ind. Ltd. | 16,272 | 33.8 | 5.55 | 16.6% |
Which Mutual Funds Hold Bayer Cropscience Ltd?
Frequently Asked Questions about Bayer Cropscience Ltd
Bayer Cropscience Ltd (BAYERCROP) closed at ₹3,348.4 on NSE on 19 November 2026, down 3.4 (0.1%) from the previous close.
Bayer Cropscience Ltd trades on the NSE (National Stock Exchange of India) under the symbol BAYERCROP.
Bayer Cropscience Ltd has a trailing twelve-month P/E (price-to-earnings) ratio of 310.0.
Bayer Cropscience Ltd has a dividend yield of 4.41%.
Bayer Cropscience Ltd's 52-week high is ₹5,063.0 and its 52-week low is ₹3,225.0.
Bayer Cropscience Ltd has a market capitalisation of ₹15,266 crore.
Bayer Cropscience Ltd has a TopFund Quality Score of 51/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Bayer Cropscience Ltd?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.